Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Dec 2002

Silva Jose M, Silva Javier, Sanchez Antonio, Garcia Jose M, Dominguez Gemma, Provencio Mariano, Sanfrutos Luis, Jareño Eugenia, Colas Antonio, España Pilar, Bonilla Felix

Abstract excerpt

PURPOSE: We examine prospectively whether the presence of plasma DNA with tumor characteristics before mastectomy is a predictive factor related to recurrence and disease-free survival (DFS). EXPERIMENTAL DESIGN: A series of 147 patients with breast carcinomas, selected sequentially, was analyzed. The characterization of plasma DNA, based on similar alterations in tumor and plasma DNA, was achieved with six...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Loss of Heterozygosity

Share to Lymphatic Metastasis

Share to Mastectomy

Share to Neoplasm Invasiveness

Share to Survival Rate

Source

Identifiers

PMID: 12473587

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.PMID 12473587Read ↗

Persistence of tumor DNA in plasma of breast cancer patients after mastectomy.Semantic proximity Read ↗

Circulating DNA as biomarker in breast cancer.Semantic proximity Read ↗

Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patientsSemantic proximity Read ↗

p53 mutation in plasma DNA and its prognostic value in breast cancer patients.Semantic proximity Read ↗

Circulating tumor DNA as a predictive marker of recurrence for patients with stage II-III breast cancer treated with neoadjuvant therapySemantic proximity Read ↗

Tumor-specific DNA in plasma of breast cancer patients.Semantic proximity Read ↗

Longitudinal dynamics of circulating tumor DNA for treatment monitoring in patients with breast cancer recurrence.Semantic proximity Read ↗

Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer ProgressionSemantic proximity Read ↗

Clinical factors associated with circulating tumor <scp>DNA</scp> (ct<scp>DNA</scp>) in primary breast cancerSemantic proximity Read ↗

Sox17 Promoter Methylation in Plasma DNA Is Associated With Poor Survival and Can Be Used as a Prognostic Factor in Breast CancerSemantic proximity Read ↗

Circulating cell-free DNA and its integrity as a prognostic marker for breast cancerSemantic proximity Read ↗

Association of preoperative and postoperative circulating tumour DNA (ctDNA) with PIK3CA gene mutation with risk of recurrence in patients with non-metastatic breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.